XML 21 R11.htm IDEA: XBRL DOCUMENT v3.25.3
Note 4 - Net Income Per Share
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 4 – Net Income Per Share:

 

The Company’s basic net income per share is computed based on the weighted average number of shares of common stock outstanding for the period. Diluted net income per share includes the effect of the Company’s outstanding stock options, stock appreciation rights, nonvested shares of restricted stock and nonvested performance shares, if the inclusion of these items is dilutive.

 

The following table presents a reconciliation of basic and diluted net income per share for the periods presented:

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2025

   

2024

   

2025

   

2024

 

Net income used in the computation of basic and diluted net income per share (in thousands)

  $ 2,744     $ 5,403     $ 3,537     $ 9,915  
                                 

Weighted average shares outstanding - basic

    14,738,863       16,107,549       15,050,834       16,118,885  

Dilutive common stock equivalents

    380,187       436,441       371,310       470,029  

Weighted average shares outstanding - diluted

    15,119,050       16,543,990       15,422,144       16,588,914  

Net income per share:

                               

Basic

  $ 0.19     $ 0.34     $ 0.24     $ 0.62  

Diluted

  $ 0.18     $ 0.33     $ 0.23     $ 0.60  

 

Awards to purchase 654,495 and 309,778 shares of common stock with weighted average exercise prices of $16.52 and $21.44 per share were outstanding during the three months ended September 30, 2025 and 2024, respectively, but were not included in the computation of diluted net income per share because the awards’ exercise prices were greater than the average market price of the common shares.

 

Awards to purchase 549,430 and 335,071 shares of common stock with weighted average exercise prices of $18.11 and $21.40 per share were outstanding during the nine months ended September 30, 2025 and 2024, respectively, but were not included in the computation of diluted net income per share because the awards’ exercise prices were greater than the average market price of the common shares.